サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1401434

動物用狂犬病ワクチンの世界市場規模調査＆予測、用途別、地域別分析、2023-2030年

Global Rabies Veterinary Vaccines Market Size study & Forecast, by Application (Companion Animals, Livestock Animals, Wildlife Animals) and Regional Analysis, 2023-2030
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
動物用狂犬病ワクチンの世界市場規模調査＆予測、用途別、地域別分析、2023-2030年
出版日: 2023年11月15日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

動物用狂犬病ワクチンの世界市場は、2022年には約5億8,480万米ドルと評価され、予測期間2023-2030年には4.10%以上の健全な成長率で成長すると予測されています。

狂犬病ワクチンは、通常、犬やコウモリに噛まれることで発症する狂犬病を予防する効果的な方法です。安全で効果的な狂犬病ワクチンが数多くあり、ウイルスに暴露される前または暴露後に投与することができます。狂犬病ワクチン市場の成長は、新興諸国における動物の狂犬病ワクチン接種率の上昇、人獣共通感染症に対する意識の高まり、動物の狂犬病を根絶するための政府のイニシアチブの高まりといった要因によって牽引されています。

先進国ではペットの飼育率が上昇しており、これが市場成長の原動力となっています。米国ペット用品協会（APPA）が実施した2021-2022年全国ペット飼育者調査によると、米国世帯の70％にあたる約9,050万世帯がペットを飼育しています。予測期間中の市場成長を促進する主な要因の1つは、世界の狂犬病患者数の増加です。2021年5月現在、世界保健機関（WHO）によると、犬はヒトの狂犬病感染の最大99％を担っており、世界のヒト狂犬病死亡原因の第1位となっています。毎年、世界で2,900万人以上がワクチンによる咬傷を求めており、狂犬病が疑われる感染者の40.0%は15歳未満の乳幼児である、と同出典は述べています。新興国市場における牛や家禽の飼育頭数の増加により、動物用ワクチン市場は安定した成長が見込まれています。狂犬病は予防可能なウイルス性疾患だが、予防や治療が間に合わなければ、動物の中枢神経系に影響を及ぼし、脳の炎症や死に至る可能性があります。米国国立感染症財団の記事によると、米国では毎年5,000件近くの動物の狂犬病患者が報告されており、その90％以上が野生動物で発生している一方、犬や猫などの家畜が動物の狂犬病事件の約10％を占めています。さらに、抗生物質耐性菌の増殖を抑制するワクチンの研究開発への投資が増加していることも、動物用ワクチン市場の成長を後押ししています。このような動物用ワクチン需要の高まりにより、多くの新しいワクチンが登場しています。技術的に先進的なサービスプロバイダーが市場を押し上げると予想されるが、ワクチンの保管コストが高く、動物の健康に対する意識が低いことが、2023～2030年の予測期間を通じて市場の成長を阻害しています。

動物用狂犬病ワクチンの世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。2022年、北米はペット人口が多く、獣医ヘルスケア支出が大きいため、市場を独占しました。確立された動物用製薬会社や政府機関は、狂犬病対策として集団予防接種プログラムや野生動物の狂犬病エサワクチンキャンペーンの実施に取り組んでいます。また、ペットの飼い主も致命的な感染症を予防する意識が高まっています。アジア太平洋地域は、野良犬の数が多いことから、予測期間中に最も急成長する地域となる見込みです。同地域では、2030年までに狂犬病を根絶するため、主要企業や政府組織と連携した犬の集団予防接種プログラムなど、複数の戦略を実施しています。例えば、2022年4月には、狂犬病対策イニシアチブの一環として、狂犬病対策世界アライアンス（GARC）とベーリンガーインゲルハイムがフィリピン、インドネシア、ベトナム、マレーシアで狂犬病集団予防接種プログラムを開催し、12,000頭の動物にワクチンを接種しました。

本調査の目的は、近年のさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における業界の質的・量的側面を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 世界の動物用狂犬病ワクチン市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 産業の発展
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 動物用狂犬病ワクチンの世界市場力学

  • 動物用狂犬病ワクチン市場の影響分析（2020-2030年）
    • 市場促進要因
      • 人獣共通感染症に対する意識の高まり
      • ペット飼育率の増加
    • 市場の課題
      • 動物用狂犬病ワクチンの高い保管コスト
      • 動物ヘルスケアに対する意識の欠如
    • 市場機会
      • 技術的進歩とサービスの成長
      • 狂犬病撲滅に向けた政府の取り組みの高まり

第4章 動物用狂犬病ワクチンの世界市場産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治的
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 動物用狂犬病ワクチンの世界市場：用途別

  • 市場スナップショット
  • 動物用狂犬病ワクチンの世界市場：用途別、実績 - ポテンシャル分析
  • 動物用狂犬病ワクチンの世界市場：用途別推定・予測、2020～2030年
  • 動物用狂犬病ワクチンの世界市場、サブセグメント分析
    • コンパニオンアニマル
    • 畜産動物
    • 野生動物

第6章 動物用狂犬病ワクチンの世界市場：地域別分析

  • 主要国
  • 主な新興国
  • 動物用狂犬病ワクチン市場、地域別市場スナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカ
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他中東とアフリカ

第7章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Sanofi SA
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 最近の動向
    • Merck & Co., Inc.（MSD Animal Health）
    • Indian Immunologicals Ltd.
    • Boehringer Ingelheim International GmbH（Animal Health）
    • Zoetis Inc.
    • Virbac
    • BroadChem Philippines Biopharma Corporation
    • Elanco Animal Health Incorporated
    • Ceva Sante Animale
    • BiogenesisBago

第8章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Rabies Veterinary Vaccines Market, report scope
  • TABLE 2. Global Rabies Veterinary Vaccines Market estimates & forecasts by Region 2020-2030 (USD Million)
  • TABLE 3. Global Rabies Veterinary Vaccines Market estimates & forecasts by Application 2020-2030 (USD Million)
  • TABLE 4. Global Rabies Veterinary Vaccines Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 5. Global Rabies Veterinary Vaccines Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 6. Global Rabies Veterinary Vaccines Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 7. Global Rabies Veterinary Vaccines Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 8. Global Rabies Veterinary Vaccines Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 9. Global Rabies Veterinary Vaccines Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 10. Global Rabies Veterinary Vaccines Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 11. Global Rabies Veterinary Vaccines Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 12. Global Rabies Veterinary Vaccines Market by segment, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 13. Global Rabies Veterinary Vaccines Market by region, estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 14. U.S. Rabies Veterinary Vaccines Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 15. U.S. Rabies Veterinary Vaccines Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 16. U.S. Rabies Veterinary Vaccines Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 17. Canada Rabies Veterinary Vaccines Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 18. Canada Rabies Veterinary Vaccines Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 19. Canada Rabies Veterinary Vaccines Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 20. UK Rabies Veterinary Vaccines Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 21. UK Rabies Veterinary Vaccines Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 22. UK Rabies Veterinary Vaccines Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 23. Germany Rabies Veterinary Vaccines Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 24. Germany Rabies Veterinary Vaccines Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 25. Germany Rabies Veterinary Vaccines Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 26. France Rabies Veterinary Vaccines Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 27. France Rabies Veterinary Vaccines Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 28. France Rabies Veterinary Vaccines Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 29. Italy Rabies Veterinary Vaccines Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 30. Italy Rabies Veterinary Vaccines Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 31. Italy Rabies Veterinary Vaccines Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 32. Spain Rabies Veterinary Vaccines Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 33. Spain Rabies Veterinary Vaccines Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 34. Spain Rabies Veterinary Vaccines Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 35. RoE Rabies Veterinary Vaccines Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 36. RoE Rabies Veterinary Vaccines Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 37. RoE Rabies Veterinary Vaccines Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 38. China Rabies Veterinary Vaccines Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 39. China Rabies Veterinary Vaccines Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 40. China Rabies Veterinary Vaccines Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 41. India Rabies Veterinary Vaccines Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 42. India Rabies Veterinary Vaccines Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 43. India Rabies Veterinary Vaccines Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 44. Japan Rabies Veterinary Vaccines Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 45. Japan Rabies Veterinary Vaccines Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 46. Japan Rabies Veterinary Vaccines Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 47. South Korea Rabies Veterinary Vaccines Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 48. South Korea Rabies Veterinary Vaccines Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 49. South Korea Rabies Veterinary Vaccines Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 50. Australia Rabies Veterinary Vaccines Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 51. Australia Rabies Veterinary Vaccines Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 52. Australia Rabies Veterinary Vaccines Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 53. RoAPAC Rabies Veterinary Vaccines Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 54. RoAPAC Rabies Veterinary Vaccines Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 55. RoAPAC Rabies Veterinary Vaccines Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 56. Brazil Rabies Veterinary Vaccines Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 57. Brazil Rabies Veterinary Vaccines Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 58. Brazil Rabies Veterinary Vaccines Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 59. Mexico Rabies Veterinary Vaccines Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 60. Mexico Rabies Veterinary Vaccines Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 61. Mexico Rabies Veterinary Vaccines Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 62. RoLA Rabies Veterinary Vaccines Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 63. RoLA Rabies Veterinary Vaccines Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 64. RoLA Rabies Veterinary Vaccines Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 65. Saudi Arabia Rabies Veterinary Vaccines Market estimates & forecasts, 2020-2030 (USD Million)
  • TABLE 66. South Africa Rabies Veterinary Vaccines Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 67. RoMEA Rabies Veterinary Vaccines Market estimates & forecasts by segment 2020-2030 (USD Million)
  • TABLE 68. List of secondary sources, used in the study of global Rabies Veterinary Vaccines Market
  • TABLE 69. List of primary sources, used in the study of global Rabies Veterinary Vaccines Market
  • TABLE 70. Years considered for the study
  • TABLE 71. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Rabies Veterinary Vaccines Market, research methodology
  • FIG 2. Global Rabies Veterinary Vaccines Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Rabies Veterinary Vaccines Market, key trends 2022
  • FIG 5. Global Rabies Veterinary Vaccines Market, growth prospects 2023-2030
  • FIG 6. Global Rabies Veterinary Vaccines Market, porters 5 force model
  • FIG 7. Global Rabies Veterinary Vaccines Market, pest analysis
  • FIG 8. Global Rabies Veterinary Vaccines Market, value chain analysis
  • FIG 9. Global Rabies Veterinary Vaccines Market by segment, 2020 & 2030 (USD Million)
  • FIG 10. Global Rabies Veterinary Vaccines Market by segment, 2020 & 2030 (USD Million)
  • FIG 11. Global Rabies Veterinary Vaccines Market by segment, 2020 & 2030 (USD Million)
  • FIG 12. Global Rabies Veterinary Vaccines Market by segment, 2020 & 2030 (USD Million)
  • FIG 13. Global Rabies Veterinary Vaccines Market by segment, 2020 & 2030 (USD Million)
  • FIG 14. Global Rabies Veterinary Vaccines Market, regional snapshot 2020 & 2030
  • FIG 15. North America Rabies Veterinary Vaccines Market 2020 & 2030 (USD Million)
  • FIG 16. Europe Rabies Veterinary Vaccines Market 2020 & 2030 (USD Million)
  • FIG 17. Asia pacific Rabies Veterinary Vaccines Market 2020 & 2030 (USD Million)
  • FIG 18. Latin America Rabies Veterinary Vaccines Market 2020 & 2030 (USD Million)
  • FIG 19. Middle East & Africa Rabies Veterinary Vaccines Market 2020 & 2030 (USD Million)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Rabies Veterinary Vaccines Market is valued approximately at USD 584.8 million in 2022 and is anticipated to grow with a healthy growth rate of more than 4.10% over the forecast period 2023-2030. The rabies vaccine is an effective way to prevent rabies, which is usually caused by being bitten by a dog or bat. There are many safe and effective rabies vaccines available that can be administered before or after exposure to the virus. The rabies vaccines market growth is driven by factors such as the increase in animal rabies vaccination coverage in developing countries, a greater awareness of zoonotic diseases and growing government initiatives to eradicate animal rabies.

The pet ownership rate is increasing in developed countries, which is driving the market growth. According to the 2021-2022 National Pet Owners Survey conducted by the American Pet Products Association (APPA), about 90.5 million families, or 70% of US households, own a pet. One of the major factors driving market growth over the forecast period is the increasing number of rabies cases worldwide. As of May 2021, dogs are responsible for up to 99% of all human rabies transmissions, making them the leading cause of human rabies mortality worldwide, according to the World Health Organization (WHO). Each year, over 29.0 million people globally seek vaccine bites, and 40.0% of those infected with suspected rabies are infants under 15 years of age, according to the same source. The animal vaccines market is projected to experience steady growth, due to the rising number of cattle and poultry in developing nations. Rabies is a viral disease that can be prevented, but if not prevented or treated in time, it can affect the central nervous system of animals, leading to brain inflammation and death. According to a National Foundation for Infectious Diseases article, the U.S. reports nearly 5,000 rabies cases in animals every year, with over 90% of cases occurring in wildlife, while domestic animals like dogs and cats account for approximately 10% of animal rabies incidents. Moreover, the animal vaccines market's growth is fueled by an increase in investment for research and development of vaccines that inhibit the growth of antibiotic-resistant organisms. This rise in demand for animal vaccines has led to the emergence of many new vaccines. Technologically advanced service providers are expected to boost the market, but the high storage cost of the vaccines and lack of awareness about animal health are stifling market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Rabies Veterinary Vaccines Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. In 2022, North America dominated the market due to a high pet population and significant veterinary healthcare spending. Established veterinary pharmaceutical companies and government organizations are working to implement mass vaccination programs and wildlife rabies bait-vaccine campaigns to combat rabies. Pet owners are also becoming more aware of preventing deadly infections. Asia Pacific is expected to be the fastest-growing region over the forecast period due to a large stray dog population. The region is implementing multiple strategies to eradicate rabies by 2030, including mass dog vaccination programs in collaboration with key players and government organizations. For example, in April 2022, as part of the rabies control initiative, the Global Alliance for Rabies Control (GARC) and Boehringer Ingelheim organized a mass rabies vaccination program in the Philippines, Indonesia, Vietnam, and Malaysia, vaccinating 12,000 animals.

Major market player included in this report are:

  • Sanofi SA
  • Merck & Co., Inc. (MSD Animal Health)
  • Indian Immunologicals Ltd.
  • Boehringer Ingelheim International GmbH (Animal Health)
  • Zoetis Inc.
  • Virbac
  • BroadChem Philippines Biopharma Corporation
  • Elanco Animal Health Incorporated
  • Ceva Sante Animale
  • BiogenesisBago

Recent Developments in the Market:

  • In June 2022, Ceva Sante Animale acquired Artemis Technologies, Inc., a Canadian company that produces oral rabies vaccines. This acquisition allowed the company to broaden their range of veterinary vaccine by adding ONRAB, a recombinant oral vaccine that has shown promising results in trials conducted on wild skunks and raccoons in the U.S.

Global Rabies Veterinary Vaccines Market Report Scope:

  • Historical Data - 2020 - 2021
  • Base Year for Estimation - 2022
  • Forecast period - 2023-2030
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered - Application, Region
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Application:

  • Companion Animals
  • Livestock Animals
  • Wildlife Animals

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
    • 1.2.1. Rabies Veterinary Vaccines Market, by Region, 2020-2030 (USD Million)
    • 1.2.2. Rabies Veterinary Vaccines Market, by Application, 2020-2030 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Rabies Veterinary Vaccines Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Rabies Veterinary Vaccines Market Dynamics

  • 3.1. Rabies Veterinary Vaccines Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing awareness regarding zoonotic diseases
      • 3.1.1.2. Growing pet ownership rates
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Storage Cost of Rabies Veterinary Vaccines
      • 3.1.2.2. Lack of animal healthcare awareness
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Growing technological Advancements and services
      • 3.1.3.2. Growing government initiatives to eradicate animal rabies

Chapter 4. Global Rabies Veterinary Vaccines Market: Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economic
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Rabies Veterinary Vaccines Market, by Application

  • 5.1. Market Snapshot
  • 5.2. Global Rabies Veterinary Vaccines Market by Application, Performance - Potential Analysis
  • 5.3. Global Rabies Veterinary Vaccines Market Estimates & Forecasts by Application 2020-2030 (USD Million)
  • 5.4. Rabies Veterinary Vaccines Market, Sub Segment Analysis
    • 5.4.1. Companion Animals
    • 5.4.2. Livestock Animals
    • 5.4.3. Wildlife Animals

Chapter 6. Global Rabies Veterinary Vaccines Market, Regional Analysis

  • 6.1. Top Leading Countries
  • 6.2. Top Emerging Countries
  • 6.3. Rabies Veterinary Vaccines Market, Regional Market Snapshot
  • 6.4. North America Rabies Veterinary Vaccines Market
    • 6.4.1. U.S. Rabies Veterinary Vaccines Market
      • 6.4.1.1. Application breakdown estimates & forecasts, 2020-2030
    • 6.4.2. Canada Rabies Veterinary Vaccines Market
  • 6.5. Europe Rabies Veterinary Vaccines Market Snapshot
    • 6.5.1. U.K. Rabies Veterinary Vaccines Market
    • 6.5.2. Germany Rabies Veterinary Vaccines Market
    • 6.5.3. France Rabies Veterinary Vaccines Market
    • 6.5.4. Spain Rabies Veterinary Vaccines Market
    • 6.5.5. Italy Rabies Veterinary Vaccines Market
    • 6.5.6. Rest of Europe Rabies Veterinary Vaccines Market
  • 6.6. Asia-Pacific Rabies Veterinary Vaccines Market Snapshot
    • 6.6.1. China Rabies Veterinary Vaccines Market
    • 6.6.2. India Rabies Veterinary Vaccines Market
    • 6.6.3. Japan Rabies Veterinary Vaccines Market
    • 6.6.4. Australia Rabies Veterinary Vaccines Market
    • 6.6.5. South Korea Rabies Veterinary Vaccines Market
    • 6.6.6. Rest of Asia Pacific Rabies Veterinary Vaccines Market
  • 6.7. Latin America Rabies Veterinary Vaccines Market Snapshot
    • 6.7.1. Brazil Rabies Veterinary Vaccines Market
    • 6.7.2. Mexico Rabies Veterinary Vaccines Market
  • 6.8. Middle East & Africa Rabies Veterinary Vaccines Market
    • 6.8.1. Saudi Arabia Rabies Veterinary Vaccines Market
    • 6.8.2. South Africa Rabies Veterinary Vaccines Market
    • 6.8.3. Rest of Middle East & Africa Rabies Veterinary Vaccines Market

Chapter 7. Competitive Intelligence

  • 7.1. Key Company SWOT Analysis
    • 7.1.1. Company 1
    • 7.1.2. Company 2
    • 7.1.3. Company 3
  • 7.2. Top Market Strategies
  • 7.3. Company Profiles
    • 7.3.1. Sanofi SA
      • 7.3.1.1. Key Information
      • 7.3.1.2. Overview
      • 7.3.1.3. Financial (Subject to Data Availability)
      • 7.3.1.4. Product Summary
      • 7.3.1.5. Recent Developments
    • 7.3.2. Merck & Co., Inc. (MSD Animal Health)
    • 7.3.3. Indian Immunologicals Ltd.
    • 7.3.4. Boehringer Ingelheim International GmbH (Animal Health)
    • 7.3.5. Zoetis Inc.
    • 7.3.6. Virbac
    • 7.3.7. BroadChem Philippines Biopharma Corporation
    • 7.3.8. Elanco Animal Health Incorporated
    • 7.3.9. Ceva Sante Animale
    • 7.3.10. BiogenesisBago

Chapter 8. Research Process

  • 8.1. Research Process
    • 8.1.1. Data Mining
    • 8.1.2. Analysis
    • 8.1.3. Market Estimation
    • 8.1.4. Validation
    • 8.1.5. Publishing
  • 8.2. Research Attributes
  • 8.3. Research Assumption